GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper peptide found in human plasma, saliva, and tissues. It plays a key role in wound healing, tissue repair, and cellular regeneration by influencing gene expression, promoting collagen and elastin production, and supporting the body's natural repair processes. First discovered in the 1970s, GHK-Cu levels naturally decline with age, leading to a decrease in the body's ability to repair and maintain healthy skin, hair, and connective tissues.

GHK-Cu has been widely studied for its potential regenerative properties, including its ability to:

• Promote skin rejuvenation by stimulating collagen and elastin production, leading to improved firmness, elasticity, and hydration.
• Enhance wound healing and tissue repair by activating stem cells, reducing inflammation, and supporting the extracellular matrix.
• Support hair follicle health by prolonging the hair growth (anagen) phase and encouraging new hair growth in thinning areas.
• Reduce oxidative stress by acting as an antioxidant, helping to neutralize free radicals and protect cells from damage.
• Modulate inflammation by regulating cytokines and promoting a balanced immune response.

Due to its multi-functional properties, GHK-Cu is commonly used in anti-aging, regenerative medicine, and hair restoration. Research suggests that it may help improve skin texture, reduce fine lines, accelerate healing after procedures, and support overall tissue vitality. However, while GHK-Cu has been extensively studied for its potential benefits, it is important to note that it is a compounded medication and has not been evaluated or approved by the FDA for any specific medical condition.

GHK-Cu is available by prescription only and should be used under the guidance of a licensed healthcare provider. Patients receive a personalized prescription from a 503A compounding pharmacy, ensuring quality and regulatory compliance for individual use.

GHK-Cu may be beneficial for individuals looking to support skin rejuvenation, wound healing, hair follicle health, and overall tissue vitality under the guidance of a qualified healthcare provider.

Those who are seeking collagen support, hair regrowth assistance, or recovery from minor skin injuries may find GHK-Cu injections useful as part of a comprehensive wellness plan.

It is important to note that GHK-Cu is not FDA-approved for any specific condition and should only be used as prescribed and dispensed by a 503A compounding pharmacy in compliance with all applicable regulations.

Your GHK-Cu prescription is compounded in a licensed 503A compounding pharmacy that follows strict quality and safety standards. Unlike mass-manufactured medications, 503A pharmacies create personalized prescriptions based on individual patient needs, ensuring a high level of customization and regulatory oversight.

Each order includes one (1) vial of GHK-Cu with a concentration of 10mg/mL in a 5mL vial (50mg total). When taken at the recommended dose of 2mg (20 units) three times per week, the supply is designed to last approximately 8 weeks. Please follow the dosing instructions provided by your healthcare provider for optimal results.

The suggested protocol for GHK-Cu injections is 2mg (20 units) administered subcutaneously, three times per week for a total of 6mg per week. Always follow the guidance of your healthcare provider to determine the best dosage and frequency for your specific needs.

GHK-Cu injections are typically administered subcutaneously (under the skin), with common injection sites including the thigh, abdomen, or upper arm. Detailed administration instructions will be provided with your prescription. If you are unfamiliar with injections, consult a healthcare professional for guidance or assistance.

GHK-Cu is a compounded peptide that should only be used under the supervision of a licensed healthcare provider. While early research suggests potential benefits, it is not FDA-approved, and its use may not be appropriate for everyone.

Individuals with the following conditions should avoid GHK-Cu or seek specialist approval before use:

• Active Cancer or History of Cancer - Since GHK-Cu influences cellular signaling and regeneration, there is concern that it may affect abnormal cell growth. Patients with cancer should consult an oncologist before use.
• Pregnancy or Breastfeeding - There is insufficient research on the safety of GHK-Cu for pregnant or breastfeeding individuals. As a precaution, it should not be used during pregnancy or lactation.
• Active Infections - Individuals with acute bacterial, viral, or fungal infections should avoid use until the infection resolves, as GHK-Cu may modulate immune response.
• Severe Liver or Kidney Disease - Because peptides are metabolized by the liver and excreted by the kidneys, individuals with significant organ impairment should avoid use or undergo close monitoring.
• Blood Clotting Disorders or Use of Blood Thinners - GHK-Cu’s effects on angiogenesis (blood vessel formation) are not well understood in individuals taking anticoagulants (e.g., warfarin, heparin) or those with clotting disorders.
• Autoimmune Disorders or Immunosuppressive Therapy - GHK-Cu's impact on immune function is still being studied. Patients with autoimmune diseases (e.g., lupus, rheumatoid arthritis) or those taking immunosuppressants should consult a specialist.
• Pediatric Patients (Under 18 Years Old) - There is limited clinical data on the safety of GHK-Cu in children, so its use in this population is not recommended unless prescribed by a pediatric specialist.

GHK-Cu is generally well-tolerated when used under medical supervision; however, some individuals may experience mild side effects, including:

• Injection site reactions - Mild redness, swelling, or irritation at the injection site.
• Temporary dizziness or nausea - Some individuals report mild discomfort after injections.
• Skin sensitivity - In rare cases, individuals with sensitive skin may notice temporary dryness or irritation.

If you experience any unexpected or concerning side effects, discontinue use and consult your healthcare provider immediately.

Yes, GHK-Cu may be used alongside other peptides under the guidance of a licensed healthcare provider. Some patients combine GHK-Cu with NAD+ for cellular health support or with GLP-1 receptor agonists (e.g., GLP-1 + B12, GLP-1/GIP + B12) for weight management. However, combining peptides should always be done with medical supervision to ensure proper dosing and minimize potential interactions.

Yes! Your prescription includes alcohol wipes, syringes, and all necessary supplies for proper administration.

Yes, while a licensed healthcare provider will review your information before prescribing GHK-Cu, we encourage you to inform your primary care provider about all medications and supplements you take. Your primary doctor has a more complete understanding of your overall health and can help ensure that GHK-Cu is appropriate for you.

GHK-Cu is not FDA-approved for the treatment, prevention, or cure of any medical condition. It is a compounded medication that should only be used under medical supervision and dispensed by a 503A compounding pharmacy in compliance with regulatory standards. Individual results may vary, and ongoing research is still evaluating the full range of GHK-Cu’s effects. Patients should discuss potential risks and benefits with their provider to determine if peptide therapy is appropriate for their specific health needs.